Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Coviccine in Healthy Children and Adolescents (6-17 Years)
NCT05013983Phase 2Withdrawn
- Sponsor
- WestVac Biopharma
- Start
- Jul 2024
- Primary completion
- Dec 2024
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of recombinant COVID-19 (XBB) trimer protein vaccine in coronavirus disease 2019 (COVID-19), sponsored by WestVac Biopharma. Planned start Jul 2024; status: withdrawn.
02
Drugs
recombinant COVID-19 (XBB) trimer protein vaccine
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT05013983.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05013983.